Skip to main content
OpenTrials
Completed

NCT Number: NCT04280835

Psychoeducation in Patients Who Diagnosed With Schizophrenia

People with schizophrenia are faced with social problems such as repeated hospitalizations, stigma with lack of social skills, unemployment, lack of necessary and adequate health care and education due to lack of adequate care in the community they live in. It is known that psychoeducation practices aimed at developing social skills in schizophrenia give patients new skills and these skills continue for many years. This study aimed to determine the effect of group psychoeducation that focused on social skill development on treatment adaptation, quality of life and well-being in schizophrenia patients and the interaction between these variables over time.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Quality of Life Behavior Compliance, Treatment Health Behavior Mental Disorders Patient Acceptance of Health Care Patient Compliance Schizophrenia Schizophrenia Spectrum and Other Psychotic Disorders Treatment Adherence and Compliance Well-Being

Age range

18 year–61 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Merve Kızılırmak Tatu

Ankara, 06500, Turkey (Türkiye)

About this study

The aim is to determine the effect of group psychoeducation that focused on social skill development on treatment adaptation, quality of life and well-being in schizophrenia patients and the interaction between these variables over time.

The study was conducted with 42 schizophrenia patients (n=21 intervention group; n=21 control group) using a quasi-experimental research design. Patients were evaluated using a pre-test, post-test, monitoring test, "Medication Adherence Rating Scale (MARS)", "Quality of Life Scale for Schizophrenia (QLSS)" and "Flourishing Scale" (FS). The measurements were taken 3 times: pre test, post-test and 3-months post-test.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Volunteering
  • Being 18 and over being literate
  • Having been diagnosed with schizophrenia for at least three months
  • Taking oral antipsychotics
  • Being in remission.

Exclusion criteria

  • Being in an acute period of exacerbation
  • Actively using alcohol or psychoactive substances
  • Having mental retardation or dementia
  • Having another psychiatric illness that makes it impossible to cooperate.

Treatment and study plan

Group Psychoeducation that Focused on Social Skill Development

Behavioral

Psychoeducation Program consists of; Preparatory Session, Recognition of Schizophrenia, Evaluating the Treatment of Schizophrenia, Stress and Coping with Stress, Improving Communication Skills, Improving Problem-solving Skills, Improving Interpersonal relationships and social activities and Evaluating Session.The sessions were held in the form of PowerPoint presentations. In the psychoeducation program, lecture, question-answer, homework, sharing experiences, group discussion, repetition, video presentation, summarization, reinforcer, and role-playing techniques were used. The day before each session, patients were phoned and reminded of the time of the session. At the end of each session, the content of the subject is given as hard copy and cookies, tea and coffee were served.

Primary outcomes

  1. Quality of Life Scale for Schizophrenia (QLSS)

    Time frame: Change from baseline to 8 weeks (also assessed at 20 weeks post-baseline)

    It evaluates the quality of life of schizophrenic patients receiving maintenance treatment. QLSS provides information about ongoing symptoms and functionality. It is a 7-degree Likert type scale applied in a semi-structured interview format. It consists of a total of four sub-dimensions and 21 questions in the form of interpersonal relationships, professional role, psychic findings and daily item use-activities. The total score of all subscales gives the total score (0-126) of quality of life.

  2. Medication Adherence Rating Scale (MARS)

    Time frame: Change from baseline to 8 weeks (also assessed at 20 weeks post-baseline)

    The scale assesses the patient's compliance behaviors and attitude to treatment. The scale consists of 10 questions to answer in the form of Yes/No (between 1-7 were poor in compliance with treatment and those with scores between 8-10 were high).

  3. Flourishing Scale (FS)

    Time frame: Change from baseline to 8 weeks (also assessed at 20 weeks post-baseline)

    It is a self-assessment scale measures an individual's level of well-being. It consists of eight items and each item is scored 1-7 points. The total score range from 8-56 points. The more the score from the scale increases the more the well-being increases.

Sponsors and collaborators

Lead sponsor

Gazi University

Other

Registry information

Official study title

The Effect of Group Psychoeducation That Focused on Social Skills Development Applied to Patients Who Diagnosed With Schizophrenia on Treatment Compliance, Quality of Life and Well-being

Important dates

Study start
2019
Primary completion
2019
Study completion
2019
First posted
Feb 21, 2020
Registry last updated
Feb 21, 2020

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.